Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

Bivolaru S, Constantin A, Vlase CM, et al. COPD Patients’ Behaviour When Involved in the Choice of Inhaler Device. Healthcare . 2023/1. Sivadasan S, Krishnan A, Dhayalan SV, et al.

FRIDAY, Jan. 3, 2025 (HealthDay News) -- For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Thomas, Liji. (2024, August 25). Widespread inhaler misuse in COPD patients: Need for training.

FDA approves Glaxo’s triple therapy inhaler for COPD The FDA approved United Kingdom-based GlaxoSmithKline’s Trelegy Ellipta, a once-daily inhaler that contains three medicines for chronic ...

In the first half of 2024, several U.S. health care professionals discussed the price of inhalers for patients with COPD on X, formerly Twitter, according to a tracker from Creation Healthcare.In ...

Over 30 million Americans have COPD, and most use some form of inhaled medicine New research suggests that the majority of COPD patients might be using their inhalers improperly, impeding their ...

Baldomero AK, Kunisaki KM, Wendt CH, et al. Guideline-discordant inhaler regimens after COPD hospitalization: associations with rurality, drive time to care, and fragmented care - a United States ...

A 2017 study looked at around 2,600 Medicare Part D and Medicare Advantage plans to determine the average out-of-pocket costs for COPD inhalers. Depending on the inhaler type, costs ranged from ...

The researchers found that the incidence of a first moderate or severe COPD exacerbation was higher in patients who received budesonide-glycopyrrolate-formoterol (hazard ratio [HR], 1.09; [95% CI ...